-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UV4R+xSO9JTQhVY0rDxsDC09h2I+RadGkq6K48X6S58DBy/m3gijeyrlcXTk2aW7 S4qPw6OiPbCBtXap5cybyQ== 0000912057-02-003171.txt : 20020414 0000912057-02-003171.hdr.sgml : 20020414 ACCESSION NUMBER: 0000912057-02-003171 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020128 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRIANGLE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001022622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 561930728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21589 FILM NUMBER: 02520769 BUSINESS ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 9194935980 MAIL ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 8-K 1 a2069076z8-k.txt 8-K --------------------------- OMB APPROVAL --------------------------- OMB Number: 3235-0060 Expires: May 31, 2000 Estimated average burden hours per response....5.00 --------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 28, 2002 ------------------------------ TRIANGLE PHARMACEUTICALS, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) DELAWARE 000-21589 56-1930728 - ---------------------------- ------------------ ----------------------------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 4 University Place, 4611 University Drive, Durham, North Carolina 27707 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (919) 493-5980 ---------------------------- - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events and Regulation FD Disclosure. On January 29, 2002, Triangle Pharmaceuticals, Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1, and is incorporated herein by reference. Item 7. Financial Statements and Exhibits. (c) Exhibits. The following document is incorporated by reference to this Report: 99.1 Press release dated January 29, 2002 SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Triangle Pharmaceuticals, Inc. --------------------------------------------------------------- (Registrant) January 29, 2002 /s/ Robert F. Amundsen, Jr. - ------------------------------ --------------------------------------------------------------- Date (Signature) Name: Robert F. Amundsen, Jr. Title: Executive Vice President & Chief Financial Officer
EX-99.1 3 a2069076zex-99_1.txt EXHIBIT 99.1 EXHIBIT 99.1
CONTACT: Mr. Robert Amundsen Mr. Chris Rallis Executive Vice President, Chief Financial Officer President, Chief Operating Officer Triangle Pharmaceuticals, Inc. Triangle Pharmaceuticals, Inc. (919) 493-5980 (919) 493-5980 www.tripharm.com www.tripharm.com - ---------------- ----------------
FOR IMMEDIATE RELEASE: - ---------------------- DR. DAVID BARRY, 58, FOUNDER AND CEO OF TRIANGLE PHARMACEUTICALS, PASSES AWAY DURHAM, N.C., JANUARY 29, 2002 -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced the death last night of Dr. David Barry, 58, founder and Chief Executive Officer of the Company. Mr. Chris Rallis, Chief Operating Officer of the Company, said, "We are obviously shocked and saddened by Dave's untimely death. Our thoughts and prayers are with his family. Those of us who have worked with him at Triangle had great admiration for him as a person and the utmost respect for his leadership. We will miss him both personally and professionally. We are heartened by the fact that Dave developed a solid senior management team at Triangle and we are determined to carry out his vision for the Company. " -----END PRIVACY-ENHANCED MESSAGE-----